课题基金 / 基金详情

PHARMACOLOGIC INDUCTION OF WEIGHT LOSS TO TREAT TYPE II DIABETES MELLITUS

PHARMACOLOGIC INDUCTION OF WEIGHT LOSS TO TREAT TYPE II DIABETES MELLITUS
药理学诱导减肥治疗 II 型糖尿病
批准号:
6117053
负责人:
JOHN P BANTLE
金额:
$4.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

JOHN P BANTLE的其他基金

相似基金

相关文献

中文摘要
翻译
减肥是大多数II型糖尿病患者的重要治疗目标。该方案是一项双盲、安慰剂对照研究,研究食欲抑制剂芬氟拉明和芬特明在治疗超重II型糖尿病患者中的有效性。然而,芬氟拉明于1997年9月从研究中退出,当时它从美国市场撤出。在10个月的所有时间点,食欲抑制剂治疗导致体重、体重指数和Hgb A1C显著降低。继续对受试者进行随访。
英文摘要
Weight loss is an important therapeutic objective for most patients with type II diabetes mellitus. This protocol was a double blind, placebo controlled study of the usefulness of the appetite suppressants fenfluramine and phentermine in the treatment of overweight type II diabetic subjects. However, fenfluramine was withdrawn from the study in September, 1997, when it was withdrawn from the U.S. market. Treatment with appetite suppressants resulted in significant reductions in body weight, body mass index and Hgb A1C at all time points through 10 months. Follow-up of subjects continues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BARI 2D: BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES
  • 批准号:
    7951647
  • 项目类别:
  • 资助金额:
    $2.71万
  • 财政年份:
    2008
  • 负责人:
    JOHN P BANTLE
  • 依托单位:
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)
  • 批准号:
    7951638
  • 项目类别:
  • 资助金额:
    $2.12万
  • 财政年份:
    2008
  • 负责人:
    JOHN P BANTLE
  • 依托单位:
BARI 2D: BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES
  • 批准号:
    7605964
  • 项目类别:
  • 资助金额:
    $5.39万
  • 财政年份:
    2006
  • 负责人:
    JOHN P BANTLE
  • 依托单位:
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)
  • 批准号:
    7605948
  • 项目类别:
  • 资助金额:
    $2.51万
  • 财政年份:
    2006
  • 负责人:
    JOHN P BANTLE
  • 依托单位:
海外基金